180 LIFE SCIENCES CORP (ATNF) Stock Price, Quote, News and Overview
NASDAQ:ATNF - Nasdaq - US68236V3024 - Common Stock - Currency: USD
ATNF Quote, Performance and Key Statistics
180 LIFE SCIENCES CORP
NASDAQ:ATNF (2/5/2025, 5:20:00 PM)
After market: 1.3909 +0 (+0.06%)1.39
+0.02 (+1.46%)
The current stock price of ATNF is 1.39 USD. In the past month the price decreased by -12.03%. In the past year, price decreased by -63.68%.
ATNF Latest News, Press Releases and Analysis
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
ATNF Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.95 | 338.85B | ||
| AMGN | AMGEN INC | 15.53 | 165.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 957.73 | 125.79B | ||
| GILD | GILEAD SCIENCES INC | 22.49 | 124.19B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.7 | 78.76B | ||
| ARGX | ARGENX SE - ADR | N/A | 40.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.64B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.34B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.26B | ||
| NTRA | NATERA INC | N/A | 23.37B | ||
| BIIB | BIOGEN INC | 8.91 | 21.21B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.55 | 15.81B |
Related stock screener links
About ATNF
Company Profile
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California and currently employs 4 full-time employees. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
Company Info
180 LIFE SCIENCES CORP
3000 El Camino Real, Bldg 4, Ste 200
Palo Alto CALIFORNIA 10019 US
CEO: James N. Woody
Employees: 4
Company Website: https://180lifesciences.com/
Phone: 16505070669
ATNF FAQ
What is the stock price of ATNF?
The current stock price of ATNF is 1.39 USD.
What is the symbol for 180 LIFE SCIENCES CORP stock?
The exchange symbol of 180 LIFE SCIENCES CORP is ATNF and it is listed on the Nasdaq exchange.
On which exchange is ATNF stock listed?
ATNF stock is listed on the Nasdaq exchange.
Is ATNF a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ATNF, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ATNF.
Does ATNF stock pay dividends?
ATNF does not pay a dividend.
What is the Price/Earnings (PE) ratio of ATNF?
ATNF does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.49).
What is the Short Interest ratio of ATNF stock?
The outstanding short interest for ATNF is 7.5% of its float.
ATNF Technical Analysis
ATNF Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ATNF. ATNF may be in some trouble as it scores bad on both profitability and health.
ATNF Financial Highlights
Over the last trailing twelve months ATNF reported a non-GAAP Earnings per Share(EPS) of -4.49. The EPS decreased by 98.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.82% | ||
| ROE | -83.61% | ||
| Debt/Equity | 0 |
ATNF Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ATNF. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 50% and a revenue growth 481.87% for ATNF